The ‘very professional’ team at Shihui Partners offers rich expertise in pharmaceutical compliance systems, licensing transactions, the regulation of new products, and investments. Miranda Jiang, Zan Zhu, and Xiaomei Li are experienced in capital markets, private equity, and venture capital, while Jing Lu is ’an outstanding partner in the compliance team’ who is regularly instructed by foreign pharmaceutical companies.
Testimonials
Collated independently by Legal 500 research team.
‘Xiaomei Li's legal team has deep experience in the medical and health industry and private equity investment and financing business, and has extremely rich project experience. The team focuses on customer needs and provides customised solutions based on business demands and project background.’
‘The Shihui Life Sciences team is very professional. In addition to professional legal knowledge, they are very familiar with the operating procedures and operating models of the medical industry. They can combine professional knowledge and understanding of the industry very well.’
‘Shihui Partners is a law firm that understands and values entrepreneurship. They know the art of achieving clients' business objectives while meeting legal requirements. This firm is able to work closely with start-up high-tech companies and accompany clients to IPO. Shihui is also unique because all members of this firm work as a team.'
‘Xiaomei Li is one of the partners in Shihui who has impressed me deeply. Not only does she have answers to all questions and problems a client may encounter during M&A and financing, but she is also a hands-on partner that every client hopes to have. She makes herself available to clients when you need her.’
‘Xiaomei Li's team of lawyers provides clients with precise and efficient legal services with its deep expertise and rich experience in the fields of biomedicine and technology. Team members not only have industry expertise, but also have rich practical experience in handling complex transactions. They continue to innovate service models and meet the personalised needs of clients through flexible billing methods and customized solutions.’
‘Xiaomei Li stands out for her deep expertise, sharp legal insights, and excellent communication skills. She has unique insights into legal issues in the biomedical and technology fields and is able to provide clients with innovative and efficient solutions.’
‘Team members have profound legal knowledge and rich practical experience in their respective professional fields, and are able to handle complex and diverse legal matters. The team focuses on understanding client needs, providing tailored legal services, and is committed to helping clients achieve their business goals.’
‘Jing Lu is an outstanding partner in the compliance team, who can clearly and accurately convey legal opinions to ensure that clients fully understand legal risks and response strategies.'
Key clients
- BridGene Biosciences, Inc.
- Suzhou Wedo Venture Capital Partnership (Limited Partnership)
- Huimei Medical Management Consulting (Beijing) Co., Ltd.
- Beijing Bluepha Microbial Technology Co., Ltd.
- Beijing Xinyang Tecnology Co., Ltd.
- Genetron Health (Beijing) Co., Ltd.
- Zhejiang Haixinzhihui Technology Co., Ltd.
- Suzhou Industrial Park Yuan Fu Venture Capital Limited Partner
- CCB International
- Nanjing Polymer Medical Technology Co., Ltd
- Tianjin Horimed Technology Co., Ltd
- Beijing Leadinno Medical Valley Co., Ltd.
- Guangzhou Reforgene Medicine Co., Ltd.
- Qiming Venture Partners
- Shanghai MicroPort EP MedTech Co., Ltd.
- Nanjing Enrui Kainuo Biotechnology Co., Ltd.
- Beijing Golden Key Gene Technology Co., Ltd.
- Yantai Lannacheng Biotechnology Co., Ltd.
- Guangzhou Weiyuan Gene Technology Co., Ltd.
- Shenzhen Wondercel Biotechnology Limited.
- Shenzhen Gaotejia Hongrui Entrepreneurship Investment Co., Ltd.
- Fu Xin Medical Limited.
- HJ Partners
- MED – FINE Capital
- Hangzhou Optech Partner Equity Investment Limited Company
- Nanjing Human Zhizao Technology Co., Ltd.
- Guangzhou Weiyuan Gene Technology Co., Ltd.
- CS Capital
- Centre Medical International Limited
Work highlights
- Advised BridGene Biosciences on its licence deal with Galapagos NV, with a USD27m upfront payment and preclinical research milestone payments, as well as over $700m in clinical and commercial milestone payments.
- Advised LYFE Capital on the investment to Chemlex Inc. with a total amount of over USD90m.
- Advised HJP Oxygen Investment Limited on an equity financing round to further bolster its research and development service capabilities in macromolecular drugs and cell and gene therapy with a total financing amount of CNY950m.
Lawyers
Practice head
The lawyer(s) leading their teams.
Jing Lu, Miranda Jiang, Xiaomei Li, Zan Zhu